460 related articles for article (PubMed ID: 32468495)
1. An Evolving Therapeutic Rationale for Targeting the α
Deutsch SI; Burket JA
Curr Top Behav Neurosci; 2020; 45():167-208. PubMed ID: 32468495
[TBL] [Abstract][Full Text] [Related]
2. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.
Lin H; Hsu FC; Baumann BH; Coulter DA; Anderson SA; Lynch DR
Mol Cell Neurosci; 2014 Jul; 61():163-75. PubMed ID: 24983521
[TBL] [Abstract][Full Text] [Related]
3. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
Faghih R; Gfesser GA; Gopalakrishnan M
Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220
[TBL] [Abstract][Full Text] [Related]
4. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
Deutsch SI; Burket JA; Benson AD; Urbano MR
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disorders.
Deutsch SI; Urbano MR; Burket JA; Herndon AL; Winebarger EE
Clin Neuropharmacol; 2011; 34(6):203-5. PubMed ID: 22094647
[TBL] [Abstract][Full Text] [Related]
6. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
[TBL] [Abstract][Full Text] [Related]
7. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.
Sanders VR; Millar NS
Pharmacol Res; 2023 May; 191():106759. PubMed ID: 37023990
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional Regulation of Aggression in Mice by Hippocampal Alpha-7 Nicotinic Acetylcholine Receptors.
Lewis AS; Pittenger ST; Mineur YS; Stout D; Smith PH; Picciotto MR
Neuropsychopharmacology; 2018 May; 43(6):1267-1275. PubMed ID: 29114104
[TBL] [Abstract][Full Text] [Related]
9. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.
Williams DK; Wang J; Papke RL
Biochem Pharmacol; 2011 Oct; 82(8):915-30. PubMed ID: 21575610
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions?
Deutsch SI; Urbano MR; Neumann SA; Burket JA; Katz E
Clin Neuropharmacol; 2010 May; 33(3):114-20. PubMed ID: 20190638
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice.
Jayaprakash P; Isaev D; Shabbir W; Lorke DE; Sadek B; Oz M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298871
[TBL] [Abstract][Full Text] [Related]
12. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
[TBL] [Abstract][Full Text] [Related]
14. Heteromeric α7β2 Nicotinic Acetylcholine Receptors in the Brain.
Wu J; Liu Q; Tang P; Mikkelsen JD; Shen J; Whiteaker P; Yakel JL
Trends Pharmacol Sci; 2016 Jul; 37(7):562-574. PubMed ID: 27179601
[TBL] [Abstract][Full Text] [Related]
15. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
[TBL] [Abstract][Full Text] [Related]
16. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
[TBL] [Abstract][Full Text] [Related]
17. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
[TBL] [Abstract][Full Text] [Related]
18. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons.
Hu M; Gopalakrishnan M; Li J
Br J Pharmacol; 2009 Dec; 158(8):1857-64. PubMed ID: 20050184
[TBL] [Abstract][Full Text] [Related]
20. Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats.
Thomsen MS; El-Sayed M; Mikkelsen JD
PLoS One; 2011; 6(11):e27014. PubMed ID: 22096516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
